CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination with Abiraterone plus Prednisone in Men with High-Risk Metastatic Hormone-Sensitive Prostate Cancer

  • Liow, Elizabeth (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date27/04/22 → 26/04/27

Keywords

  • phase 3 study
  • randomised control trial
  • prostate cancer
  • treatment safety
  • treatment efficacy